Table 2 Reactions and their perception 14 to 19 days after boost COVID-19 vaccination
ChAdOx1/ChAdOx1 | ChAdOx1/mRNA | mRNA/mRNA | |
|---|---|---|---|
(n = 487) | (n = 1943) | (n = 5715) | |
Proportion of participants with at least one reported reaction | |||
Total | 282 (57.9%) | 1675 (86.2%) | 4338 (75.9%) |
< 1d interval vaccination – registration | 131 (57.7%) | 604 (84.2%) | 2430 (74.9%) |
1–5d interval vaccination – registration | 112 (57.4%) | 611 (86.1%) | 1387 (76.3%) |
> 5d interval vaccination – registration | 39 (60.9%) | 460 (89.1%) | 521 (79.7%) |
Perception | ChAdOx1/ChAdOx1 | ChAdOx1/mRNA | mRNA/mRNA |
|---|---|---|---|
(n = 282, NA = 2) | (n = 1675) | (n = 4338, NA = 2) | |
1) Suspected association between reactions and vaccination | |||
Strongly disagree | 0 (0.0%) | 4 (0.2%) | 23 (0.5%) |
Disagree | 7 (2.5%) | 10 (0.6%) | 89 (2.1%) |
Agree | 62 (22.1%) | 194 (11.6%) | 768 (17.7%) |
Strongly agree | 211 (75.4%) | 1467 (87.6%) | 3456 (79.7%) |
2) Affection by the reactions | |||
Strongly disagree | 29 (10.4%) | 105 (6.3%) | 412 (9.5%) |
Disagree | 75 (26.8%) | 276 (16.5%) | 1110 (25.6%) |
Agree | 99 (35.4%) | 590 (35.2%) | 1501 (34.6%) |
Strongly agree | 77 (27.5%) | 704 (42.0%) | 1313 (30.3%) |
3) Long-term consequences by the reactions | |||
Strongly disagree | 233 (83.2%) | 1443 (86.1%) | 3661 (84.4%) |
Disagree | 41 (14.6%) | 193 (11.5%) | 553 (12.8%) |
Agree | 3 (1.1%) | 31 (1.9%) | 79 (1.8%) |
Strongly agree | 3 (1.1%) | 8 (0.5%) | 43 (1.0%) |